Related Experiment Video
Updated: Apr 23, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Glycemia and cognitive function in metabolic syndrome and coronary heart disease
Radhika Avadhani1, Kristen Fowler1, Corinne Barbato1
1Joslin Diabetes Center, Boston, Mass.
Insights
Higher hemoglobin A1c (HbA1c) is linked to poorer cognitive function in men with cardiovascular disease. These findings suggest that even slightly elevated blood sugar may impact brain health, highlighting the importance of glucose control.
Area of Science:
- Cardiovascular Disease Research
- Neuroscience
- Metabolic Syndrome Studies
Background:
- Elevated hemoglobin A1c (HbA1c) correlates with cognitive decline in type 2 diabetes.
- The association between HbA1c and cognitive function at lower dysglycemia levels in patients with established cardiovascular disease (CVD) is not well-established.
Purpose of the Study:
- To investigate the relationship between HbA1c levels and cognitive performance in men with metabolic syndrome and stable coronary artery disease.
- To determine if associations between HbA1c and cognitive function persist across a spectrum of glycemic control, including normoglycemia.
Main Methods:
- Cognitive performance was assessed using multiple tests: Mini-Mental State Examination, Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency.
- The study included 226 men with metabolic syndrome and established coronary artery disease, with HbA1c levels analyzed in relation to cognitive test scores.
- Statistical models adjusted for age and other cardiovascular covariates to evaluate the independent association of HbA1c with cognitive function.
Main Results:
- Hemoglobin A1c (HbA1c) was significantly associated with performance on the Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency, but not the Mini-Mental State Examination.
- In age-adjusted analyses, a 1% increase in HbA1c was linked to lower scores on the Digit Symbol Substitution Test and Rey Auditory Verbal Learning Test, and higher scores on the Trail Making Test, indicating poorer cognitive function.
- Multivariate models confirmed HbA1c's association with Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency, even after accounting for age, education, and cardiovascular factors.
Conclusions:
- Higher HbA1c levels are associated with reduced cognitive function across several domains in men with metabolic syndrome and coronary artery disease.
- These findings indicate that glycemic control, even within or near the normal range, may be important for maintaining cognitive health in this population.
- Further research is warranted to explore whether interventions aimed at lowering glucose levels can improve cognitive outcomes in individuals with cardiovascular disease.
Objective:
Higher hemoglobin A1c (HbA1c) is associated with lower cognitive function in type 2 diabetes. To determine whether associations persist at lower levels of dysglycemia in patients who have established cardiovascular disease, cognitive performance was assessed in the Targeting INflammation Using SALsalate in CardioVascular Disease (TINSAL-CVD) trial.
Methods:
The age-adjusted relationships between HbA1c and cognitive performance measured by the Mini-Mental State Examination, Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency were assessed in 226 men with metabolic syndrome and established stable coronary artery disease.
Results:
Of the participants, 61.5% had normoglycemia, 20.8% had impaired fasting glucose, and 17.7% had type 2 diabetes. HbA1c was associated with cognitive function tests of Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency (all P < .02), but not the Mini-Mental State Examination. In an age-adjusted model, a 1% (11 mmol/mol) higher HbA1c value was associated with a 5.9 lower Digit Symbol Substitution Test score (95% confidence interval [CI], -9.58 to -2.21; P < .0001); a 2.44 lower Rey Auditory Verbal Learning Test score (95% CI, -4.00 to -0.87; P < .0001); a 15.6 higher Trail Making Test score (95% CI, 5.73 to 25.6; P < .0001); and a 3.71 lower Categorical Verbal Fluency score (95% CI, -6.41 to -1.01; P < .02). In a multivariate model adjusting for age, education, and cardiovascular covariates, HbA1c remained associated with cognitive function tests of Rey Auditory Verbal Learning Test (R(2) = 0.27, P < .0001), Trail Making Test (R(2) = 0.18, P < .0001), and Categorical Verbal Fluency (R(2) = 0.20, P < .0001), although association with the Digit Symbol Substitution Test was reduced.
Conclusions:
Higher HbA1c is associated with lower cognitive function performance scores across multiple domain tests in men with metabolic syndrome and coronary artery disease. Future studies may demonstrate whether glucose lowering within the normative range improves cognitive health.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Coronary Artery Disease I: Introduction
Hypoglycemia
Hyperglycemia